ArticleMolecular cancer therapeutics2025

Characteristics of a CCL21 Gene-Modified Dendritic Cell Vaccine Utilized for a Clinical Trial in Non-Small Cell Lung Cancer.

Michael S Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.